Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
D001786:Blood Glucose; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D000078790:Insulin Secretion; D009765:Obesity / Q000150:complications / Q000378:metabolism*; D011863:Radioimmunoassay; D012964:Sodium; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D007328:Insulin; D014044:Tolbutamide; D012964:Sodium